1-5 of 5
Authors: Emily A Largent
Sort by
Journal Article
A review of public comments submitted to the Centers for Medicare and Medicaid Services in response to the 2022 National Coverage Decision on treatment for Alzheimer’s disease
Kaatje S Greenberg and others
Journal of Law and the Biosciences, Volume 12, Issue 1, January-June 2025, lsaf004, https://doi.org/10.1093/jlb/lsaf004
Published: 04 April 2025
Journal Article
‘That would be dreadful’: The ethical, legal, and social challenges of sharing your Alzheimer’s disease biomarker and genetic testing results with others
Emily A Largent and others
Journal of Law and the Biosciences, Volume 8, Issue 1, January-June 2021, lsab004, https://doi.org/10.1093/jlb/lsab004
Published: 19 May 2021
Journal Article
Regulatory flexibility for COVID-19 research
Holly Fernandez Lynch and others
Journal of Law and the Biosciences, Volume 7, Issue 1, January-June 2020, lsaa057, https://doi.org/10.1093/jlb/lsaa057
Published: 07 July 2020
Journal Article
EBOLA and FDA: reviewing the response to the 2014 outbreak, to find lessons for the future
Emily A. Largent
Journal of Law and the Biosciences, Volume 3, Issue 3, December 2016, Pages 489–537, https://doi.org/10.1093/jlb/lsw046
Published: 16 September 2016
Journal Article
Recently proposed changes to legal and ethical guidelines governing human subjects research
Emily A. Largent
Journal of Law and the Biosciences, Volume 3, Issue 1, April 2016, Pages 206–216, https://doi.org/10.1093/jlb/lsw001
Published: 06 February 2016
Advertisement
Advertisement